Understanding ADHD

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, impulsivity, and/or hyperactivity that are inconsistent with a person’s developmental level.

Similar to the evolving understanding of autism, ADHD is increasingly recognized through a neurodiversity-affirming lens. In Australia, the 2024–2025 period has seen a major policy shift toward viewing ADHD not merely as a behavioral issue, but as a fundamental difference in how the brain regulates attention, executive function, and motivation (Australian Psychological Society, 2025).

Current and Emerging Research (2025–2026)

Recent scientific advancements are moving away from a "one-size-fits-all" view toward a more personalized, biological understanding of the condition.

1. The Three Biological Biotypes

Breakthrough research published in JAMA Psychiatry and Nature Mental Health (2025–2026) utilized advanced brain-mapping to confirm that ADHD is likely a cluster of three distinct biological biotypes.

  • Biotype 1 (Emotional-Combined):Linked to alterations in the medial prefrontal cortex-pallidum circuits. This group often experiences severe combined symptoms alongside significant emotional dysregulation.

  • Biotype 2 (Hyperactive-Impulsive): Primarily associated with the "braking" circuits of the brain. The physical "accelerator" is strong, but the neural timing to inhibit an action arrives slightly too late.

  • Biotype 3 (Inattentive): Tied to specific hubs in the brain's working memory and sustained attention networks, frequently seen in females and often missed in early childhood (LifeStance Health, 2026).

2. Mitochondrial and Genetic Overlaps

2025 studies have explored the "shared biology" between ADHD and other neurodivergent conditions.

  • Mitochondrial Health: Emerging transcriptomic analysis (2025) suggests that differences in mitochondrial gene expression in the prefrontal cortex may contribute to the executive function challenges seen in ADHD, potentially leading to future nutritional or metabolic support strategies (PMC12652654, 2025).

  • Genetic Commonality: Research continues to show high genetic overlap between ADHD and Autism, explaining why up to 60–95% of autistic individuals also meet the criteria for ADHD (Cell, 2025).

The Australian Clinical Context

The diagnostic and treatment landscape in Australia is currently undergoing significant reform to improve access and reduce wait times.

1. GP Care Reform (2026)

A major shift is occurring in states like Victoria and Western Australia, where the government has begun funding accredited training for General Practitioners to diagnose and initiate treatment for ADHD (MCRI, 2026). Historically, this was restricted to specialists (paediatricians and psychiatrists), but the new model aims to make care more affordable and accessible.

2. Multi-Modal Management

Current Australian clinical practice emphasizes a "bio-psycho-social" approach:

  • Pharmacotherapy: Including stimulants and non-stimulants, with 2025–2026 guidelines focusing on managing global supply chain shortages for these medications.

  • Psychological Support: Cognitive Behavioural Therapy (CBT) and neuro-affirming coaching to help with "executive functions" like time management and organization.

  • Educational & Workplace Adjustments: Tailoring environments to reduce sensory overwhelm and maximize "hyper-focus" strengths.

Australian Resources and Support

For those navigating ADHD in Australia, the following organizations offer evidence-based resources and advocacy:

  • ADHD WA: The national body providing information for adults, parents, and professionals, with a focus on national advocacy.

  • ADHD Australia: The national body providing information for adults, parents, and professionals, with a focus on national advocacy.

  • ADHD Foundation Australia: A central hub for practical tools, including the "ADHD National Gazette" and updates on medication shortages (2025–2026).

  • ADHD Support Australia: An online hub offering expert speaker sessions, social skills programs for teens, and parenting handbooks tailored to the Australian context.

  • RANZCP (Royal Australian and New Zealand College of Psychiatrists): Access to professional position statements and clinical practice guidelines for ADHD across the lifespan.

  • Emerging Minds: Provides resources specifically for practitioners working within the neurodiversity-affirming model in community mental health.

Key References